Latest Breaking News On - Unicycive therapeutics - Page 9 : comparemela.com

Unicycive Therapeutics Strengthens Board of Directors with Appointment of Sara Kenkare-Mitra, PhD

LOS ALTOS, Calif., Sept. 06, 2023 (GLOBE NEWSWIRE) Unicycive Therapeutics, Inc. (Nasdaq: UNCY), a clinical-stage biotechnology company developing therapies for patients with kidney disease (the “Company” or “Unicycive”), today

United statesUniversity of the pacificSan franciscoShalabh guptaSara kenkare mitraTherapeutic sciencesUnicycive therapeutics incUniversity of californiaAssociation for the advancement of scienceCompany or unicyciveExchange commissionCompany board of directorsDevelopment sciences in genentechHead of researchSciences recognitionAssociation of women

Unicycive Therapeutics Strengthens Board of Directors with

Appointment adds decades of drug development experience from a seasoned executive.

United statesSan franciscoUniversity of the pacificSara kenkare mitraShalabh guptaAssociation of womenLife sciencesUniversity of californiaCompany board of directorsUnicycive therapeutics incHead of researchCompany or unicyciveAssociation for the advancement of scienceSciences recognitionDevelopment sciences in genentechExchange commission

Unicycive Therapeutics, Inc (UNCY) Appoints Sara Kenkare-Mitra to its Board

Unicycive Therapeutics, Inc (UNCY) Appoints Sara Kenkare-Mitra to its Board
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

United statesUniversity of the pacificSan franciscoSara kenkare mitraShalabh guptaCompany or unicyciveHead of researchUnicycive therapeutics incCompany board of directorsUniversity of californiaAssociation of womenLife sciencesNational academy of medicineTherapeutic sciencesDevelopment sciences in genentechSciences recognition

Unicycive Therapeutics Featured on Nasdaq Amplify Issuer Spotlight Series - Unicycive Therapeutics (NASDAQ:UNCY)

LOS ALTOS, Calif., Aug. 29, 2023 (GLOBE NEWSWIRE) Unicycive Therapeutics, Inc. (NASDAQ:UNCY), a clinical-stage biotechnology company developing therapies for patients with kidney disease (the "Company or

Shalabh guptaUnicycive therapeutics incCompany or unicyciveChief executive officerNasdaq amplify issuer spotlightUnicycive therapeutics

Unicycive Therapeutics Featured on Nasdaq Amplify Issuer Spotlight Series

Unicycive Therapeutics Featured on Nasdaq Amplify Issuer Spotlight Series
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

Shalabh guptaUnicycive therapeutics incCompany or unicyciveChief executive officerNasdaq amplify issuer spotlightUnicycive therapeutics